GLORIA TAYLOR: Open Payments
NPI 1356326896 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 70 payments from 10 companies in 2025. Trend: 2023 $1,265 · 2024 $1,226 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $203 |
| Lilly USA, LLC | 11 | $149 |
| ABBVIE INC. | 15 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $138 |
| Novo Nordisk Inc | 9 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $64 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Kerendia, OTEZLA, QULIPTA, MOUNJARO, Wegovy, JARDIANCE, HETLIOZ, EVENITY.
Industry payments across KY — which companies pay providers there.
